#USA #Miami #Healthcare Innovation #Lavior Pharma #Botanical Wound Care

Lavior Pharma Awarded at 2025 Business At Its Best Awards

On May 28, 2025, Lavior Pharma proudly announced its win of the Small Business Spotlight Award at the prestigious Business At Its Best Awards, hosted by the Florida SBDC at FIU Business. This recognition highlights their commitment to transforming wound care and skincare through innovative, clinically proven solutions.

Meet the Founders: Gilad and Anabelle Savion

Co-founders Gilad and Anabelle Savion have dedicated themselves to creating effective therapies that merge the wisdom of botanical science with advanced medical research. Proudly manufactured in the USA, Lavior Pharma's products primarily aim to expedite healing for those with diabetes and chronic skin issues.

Gilad Savion, the CEO of Lavior Pharma, expressed, “This award is more than a milestone — it's a powerful validation of our mission to merge the healing power of nature with cutting-edge clinical research.”

The Innovation Behind their Success

At the heart of Lavior's innovation lies Inula viscosa AGS-RIED, a proprietary botanical formula that has been developed over seven years. This patented extract plays a crucial role in supporting the immune system while addressing the key stages of healing — inflammation, proliferation, and remodeling. “It's the only natural pharmaceutical clinically proven in clinical trials to move chronic wounds from the inflammatory stage to healing in just three weeks,” explained Gilad.

This advancement positions Lavior Pharma as a frontrunner in the field of wound care innovation. The company’s science-backed products not only aim to prevent amputations but also significantly enhance the quality of life for individuals suffering from chronic conditions.

Commitment to Impact Lives

Anabelle Savion, the COO, stated, “At Lavior, we aim to make a positive impact and improve lives. This recognition reflects our commitment to quality, innovation, and the people we serve.” She further noted that the award honors their past achievements, the dedication of their team, and the vision they cherish for the future — one that prioritizes accessibility, affordability, and American manufacturing.

The Business At Its Best Awards brought together influential industry and government leaders, such as Paul Fitzpatrick, Associate Administrator at the U.S. Small Business Administration (SBA). He underlined the significance of investing in American manufacturing. The common theme among awardees was the demonstration of success and the ability to inspire others.

Looking Ahead to Future Expansion

Lavior's recognition comes at a pivotal moment as the company prepares to launch its products in national retail settings, including Target, alongside expanding its product range and enhancing international reach. Gilad emphasized that “global expansion is a top priority,” as they work on building strategic partnerships, bolstering education efforts, and pursuing joint ventures to make their groundbreaking therapies accessible and affordable.

In conclusion, Lavior Pharma extends heartfelt gratitude to the Florida SBDC at FIU and the community of patients, customers, clinicians, and supporters who have rallied behind their mission. “We’re building more than a company — we're building a legacy of healing,” Gilad concluded with conviction.